We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.3B
AUM Growth
+$247M
Cap. Flow
+$141M
Cap. Flow %
6.12%
Top 10 Hldgs %
17.75%
Holding
321
New
26
Increased
135
Reduced
107
Closed
32

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 18.67%
3 Industrials 18.25%
4 Consumer Discretionary 13.65%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPX
176
DELISTED
GP Strategies Corp.
GPX
$2.22M 0.1%
84,024
-5,198
-6% -$132K
GBL
177
DELISTED
GAMCO Investors, Inc.
GBL
$2.21M 0.1%
74,724
+15,894
+27% +$464K
TER icon
178
Teradyne
TER
$57.6B
$2.2M 0.1%
73,381
-528
-0.7% -$17.8K
HUBB icon
179
Hubbell
HUBB
$25B
$2.2M 0.1%
+19,430
New +$2.25M
FARM
180
DELISTED
Farmer Brothers
FARM
$2.19M 0.1%
72,448
-4,154
-5% -$137K
SRCL
181
DELISTED
Stericycle Inc
SRCL
$2.16M 0.09%
28,339
-147
-0.5% -$12.1K
HZO icon
182
MarineMax
HZO
$759M
$2.16M 0.09%
110,266
-6,645
-6% -$130K
WOOF
183
DELISTED
VCA Inc.
WOOF
$2.15M 0.09%
23,324
+2,214
+10% +$204K
ARRS
184
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$2.14M 0.09%
76,220
-1,942
-2% -$53.3K
KEYW
185
DELISTED
The KEYW Holding Corporation
KEYW
$2.12M 0.09%
226,411
-13,468
-6% -$122K
PBYI icon
186
Puma Biotechnology
PBYI
$404M
$2.11M 0.09%
+24,099
New +$1.35M
CBM
187
DELISTED
Cambrex Corporation
CBM
$2.09M 0.09%
34,973
-2,047
-6% -$115K
CBZ icon
188
CBIZ
CBZ
$2.99B
$2.08M 0.09%
138,783
-7,692
-5% -$115K
IPAR icon
189
Interparfums
IPAR
$3.99B
$2.06M 0.09%
56,272
-3,244
-5% -$117K
INGN icon
190
Inogen
INGN
$175M
$2.02M 0.09%
21,210
-1,289
-6% -$110K
RPXC
191
DELISTED
RPX Corporation
RPXC
$2M 0.09%
143,567
-9,481
-6% -$126K
AUTO
192
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$1.97M 0.09%
156,093
-9,213
-6% -$117K
ALTA
193
DELISTED
Altabancorp
ALTA
$1.96M 0.09%
72,997
-4,275
-6% -$112K
ESE icon
194
ESCO Technologies
ESE
$8.17B
$1.95M 0.08%
32,727
-2,050
-6% -$119K
ICHR icon
195
Ichor Holdings
ICHR
$2.62B
$1.94M 0.08%
96,037
-65,285
-40% -$1.39M
IWO icon
196
iShares Russell 2000 Growth ETF
IWO
$14.3B
$1.9M 0.08%
11,227
+2,538
+29% +$418K
MLAB icon
197
Mesa Laboratories
MLAB
$564M
$1.87M 0.08%
13,049
-5,000
-28% -$711K
WTW icon
198
Willis Towers Watson
WTW
$31.2B
$1.87M 0.08%
12,845
+2,951
+30% +$412K
BUSE icon
199
First Busey Corp
BUSE
$2.57B
$1.84M 0.08%
62,903
-4,689
-7% -$138K
PRFT
200
DELISTED
Perficient Inc
PRFT
$1.84M 0.08%
98,722
-5,644
-5% -$97.6K

Similar funds

Rice Hall James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Rice Hall James & Associates held 321 positions worth $2.3B, up 12% from $2.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Rice Hall James & Associates deployed $141M of net new capital in Q2 2017, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Acadia Healthcare: 610,592 shares worth $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Advanced Energy, an estimated $6.38M trimmed.

  • Rice Hall James & Associates's largest Q2 2017 buy was Acadia Healthcare: 610,592 shares worth $30.2M.
  • Rice Hall James & Associates added most to Supernus Pharmaceuticals in Q2 2017, an estimated $9.54M increase.
  • Rice Hall James & Associates's biggest Q2 2017 reduction was Advanced Energy, cutting an estimated $6.38M.
  • Rice Hall James & Associates fully exited CEB Inc. in Q2 2017, selling an estimated $22.7M.
  • Rice Hall James & Associates's ten largest holdings make up 18% of its $2.3B portfolio in Q2 2017.
  • Rice Hall James & Associates opened 26 new positions and closed 32 in Q2 2017.
  • Rice Hall James & Associates's portfolio value rose 12% quarter-over-quarter to $2.3B.

Based on Rice Hall James & Associates's 13F filing for Q2 2017, filed 2 Aug 2017.